[Home](/)/[Resources](/resources)/US 510(k) Premarket Notification

USFDA 510(k)

# US 510(k) Premarket Notification

The 510(k) premarket notification is the most common pathway for Class II medical devices. Understanding substantial equivalence, predicate selection, and submission requirements is essential for successful clearance.

Copy Link[Share on WhatsApp](https://wa.me/?text=https%3A%2F%2Fkrono-labs.com%2Fguides%2Fus-510k-premarket-notification)

At a glance

Key concepts

4

Process steps

6

FAQs

5

## Key concepts

### Substantial Equivalence

The 510(k) must demonstrate that the new device is substantially equivalent to a predicate device in safety and effectiveness.

### Predicate Device

A legally marketed device that serves as the basis for demonstrating substantial equivalence. Must be from the same classification.

### Intended Use

The general purpose of the device. Intended use must be the same as the predicate for substantial equivalence.

### Indications for Use

The specific conditions or diseases for which the device is used. Must be the same or narrower than predicate.

## Submission requirements

Device Description

Detailed description of the device including principles of operation, components, and materials.

Intended Use and Indications

Clear statement of intended use and indications for use, compared to predicate device.

Predicate Device Information

Identification of predicate device(s) and explanation of substantial equivalence.

Comparison Data

Technical data comparing the new device to the predicate including performance, safety, and effectiveness.

Labeling

Proposed labeling including instructions for use, warnings, and contraindications.

## Process steps

01

Preparation

Identify predicate device, prepare comparison data, compile required documentation.

02

Submission

Submit 510(k) through FDA's electronic submission system with required fee.

03

FDA Acceptance

FDA reviews submission for completeness. If accepted, review clock starts.

04

FDA Review

FDA reviews submission for substantial equivalence. May request additional information.

05

Decision

FDA issues Substantially Equivalent (SE) or Not Substantially Equivalent (NSE) letter.

06

Clearance

If SE, device can be marketed. If NSE, may need PMA or different pathway.

## Common compliance mistakes

Choosing wrong predicate device - predicate must be appropriate and legally marketed

Inadequate comparison data - must provide sufficient data to demonstrate substantial equivalence

Changing intended use - different intended use requires different pathway

Missing required sections - incomplete submissions are rejected and delay review

Not addressing FDA questions - timely response to FDA requests is critical

Underestimating timeline - 510(k) typically takes 3-6 months, plan accordingly

## Frequently asked questions

### What is substantial equivalence?

Substantial equivalence means the new device has the same intended use and the same technological characteristics as the predicate, or has different technological characteristics but does not raise different safety and effectiveness questions. This is the core requirement for 510(k) clearance.

### How do I find a predicate device?

Search FDA's 510(k) database for devices with similar intended use and technology. The predicate must be legally marketed in the US. Consider multiple predicates and choose the most appropriate. Novel devices without predicates may need De Novo or PMA pathways.

### How long does the 510(k) process take?

FDA's target review time is 90 days for a traditional 510(k). However, the total timeline including preparation, FDA review, and potential additional information requests typically ranges from 3-6 months. Special 510(k) may be faster.

### What is the difference between traditional and special 510(k)?

Traditional 510(k) is for devices that don't qualify for special or abbreviated pathways. Special 510(k) is for devices that meet specific criteria like changes to a legally marketed device. Special 510(k) typically requires less data and has faster review.

### What happens if FDA issues a Not Substantially Equivalent letter?

If NSE, you cannot market the device via 510(k). Options include: submitting a new 510(k) with different predicate, pursuing De Novo classification (if eligible), or pursuing PMA. The NSE letter explains the deficiencies.

**Disclaimer:** This guide provides general information about 510(k) requirements. Device-specific determinations require analysis of FDA regulations. Always verify current requirements with FDA resources or qualified regulatory professionals.

🇺🇸 US roadmap for your product

Every standard, document, and test that applies — free, no account required.

See your free roadmap[

Want an expert to take your product through 🇺🇸 US compliance for you?

One consultant from Krono's compliance team takes your product from requirements to legal sale, with a fixed quote before any work starts.

See compliance services](/services)

Learn this properly

In-depth course that teaches the full process, not just this one answer.

[Start the course — $199](/courses/17-fda-medical-device-registration-510k-hardware-startups)[Prefer to read? Get the book — $24.99](/books/17-fda-medical-device-registration-510k-hardware-startups)

Related guides

*   [FDA Medical Device RegulationComplete guide to FDA medical device regulation.](/guides/fda-medical-device-regulation)
*   [US Medical Devices ClassificationComplete guide to US medical devices classification.](/guides/us-medical-devices-classification)
*   [US PMA Premarket ApprovalComplete guide to US PMA premarket approval.](/guides/us-pma-premarket-approval)
*   [US De Novo ClassificationComplete guide to US De Novo classification.](/guides/us-de-novo-classification)